Scientific Advisory Board

Nicholas Schork

Nicholas Schork, PhD

Chair, Scientific Advisory Board & Co-Founder

Dr. Schork is a world-expert in quantitative and integrated human genetics and genomics, particularly the design and implementation of methodologies to dissect the genetic basis of complex traits and diseases, and is the lead inventor of Cypher Genomics’ biomarker discovery technology. Read more

He is Professor and Director of Human Biology at the J. Craig Venter Institute (JCVI) and the Head of Integrated Genomics at Human Longevity, Inc. Dr. Schork has published over 425 scientific articles and book chapters on the analysis of complex, multifactorial traits and diseases.

Kelly Bethel, MD

Scientific Advisor

Kelly Bethel, M.D., is a practicing hematopathologist in the Scripps Clinic Medical Group and holds an adjunct appointment at The Scripps Research Institute. In addition to her clinical practice, she is the medical director of the Blood Bank at Scripps Clinic and Green Hospital, Read more

the past program director of the Scripps Hematopathology Fellowship, and participates in various translational research activities investigating circulating tumor cells, anemia, low-grade B-cell malignancies and myelodysplasia. She completed an internship in pediatrics, a residency in anatomic and clinical pathology, and subspecialty training in hematopathology at the Naval Medical Center San Diego. She received her B.A. in English literature from Yale University and her M.D. from George Washington University School of Medicine and Health Sciences. Dr. Bethel is board certified in anatomic and clinical pathology and hematopathology.

Michael Hultner, PhD

Scientific Advisor

Michael Hultner, Ph.D. is chief scientist for Lockheed Martin’s Health and Life Sciences (HLS) division where he promotes technical and business innovations to position HLS for future new business in healthcare IT. Read more

He currently manages a diverse portfolio of healthcare innovations including big data analytics, population-scale genomics, and synthetic biology. As a Lockheed Martin Fellow, Dr. Hultner supports corporate engineering and technology with subject matter expertise, strategy, and business development in advanced information fusion, machine learning, software development, and program management. Dr. Hultner received his Ph.D. in biomedical sciences from the University of California, San Francisco and an undergraduate degree in molecular biology from University of California, San Diego.

Myla Lai-Goldman, MD

Scientific Advisor

Myla Lai-Goldman, M.D. is the chief executive officer and a founder of GeneCentric Diagnostics. Dr. Lai-Goldman spent more than 18 years at Laboratory Corporation of America Holdings (LabCorp), with the last 10 years as executive vice president, chief medical officer and chief scientific officer. Read more

During her tenure at LabCorp, she led all clinical, scientific and medical activities, including the introduction of more than 400 clinical assays. After leaving LabCorp, she became a venture partner at Hatteras Venture Partners. Dr. Lai-Goldman received her M.D. from Columbia University College of Physicians and Surgeons and is board certified in anatomic and clinical pathology.

Arnold Levine, PhD

Scientific Advisor

Dr. Levine is a pioneering cancer research scientist, having discovered the p53 tumor suppressor protein in 1979. He established the Simons Center for Systems Biology at the Institute for Advanced Study, which concentrates on research at the interface of molecular biology and the physical sciences in cancer biology. Read More

Dr. Levine was previously President of The Rockefeller University from 1998 until his retirement in February 2002 and prior to that was the Harry C. Wiess Professor in Life Sciences and former Chairman of the Department of Molecular Biology at Princeton University from 1984 until 1996. He is a member of the National Academy of Sciences and serves on a number of cancer center scientific advisory boards. Dr. Levine holds a Ph.D. in Microbiology from the University of Pennsylvania and a B.A. from Harpur College, State University of New York at Binghamton.

Catherine J. Mackey, PhD

Scientific Advisor

Catherine J. Mackey, Ph.D. is the chief executive officer of CYPrus Therapeutics. Prior to CYPrus, she was senior vice president, Pfizer Global Research and Development and Director, La Jolla Laboratories, Pfizer Inc. Dr. Mackey held many positions at Pfizer. Read more

She joined Pfizer to lead Genomic and Proteomic Sciences, which included biomarker and pharmacogenomics research. She then moved to lead Pfizer’s Strategic Alliances and was appointed senior vice president of Pfizer Global R&D and director of Pfizer La Jolla, where she is credited with leading the company to become one of Pfizer’s most successful R&D sites. In addition, Dr. Boyer was a professor at the University of California, San Francisco and an investigator for the Howard Hughes Medical Institute (HHMI). He is an elected member of the National Academy of Sciences (NAS) and a fellow in the American Academy of Arts and Sciences (AAAS). Dr. Boyer received the Albert Lasker Basic Medical Research Award in 1980 and the Shaw Prize for life science and medicine and the Albany Medical Center Prize in Medicine and Biomedical Research, each in 2004.

Diego Miralles, MD

Scientific Advisor

Dr. Miralles is Head of Janssen Healthcare Innovation within Janssen Research and Development, and leads a multi-disciplinary group focused on enhancing the value of the pharmaceutical business by identifying and integrating emerging technologies and novel partnerships in areas including genomics and clinical trials. Read more

In addition, Dr. Miralles has recently been named Head of the California regional Johnson & Johnson Innovation Center (JJIC) where he oversees the business and operational management of Janssen Labs including the initial concept development, site construction, business model architecting and company selection criteria. He graduated from the University of Buenos Aires in 1986 and completed his residency in Internal Medicine at the Mayo Clinic in Rochester, MN followed in 1990 by a Fellowship in Infectious Diseases at Cornell University-New York Hospital.